GutBrainEducation.com

GutBrainEducation.com

Menu▾

COMMON NEUROGASTROENTEROLOGY, MOTILITY & DIAGNOSTICS

The why and how of testing

ENDOSCOPIC & INTRALUMINAL PROCEDURES

Upper Endoscopy (EGD) with Mucosal Biopsies

  • What It Is: An intraluminal optical evaluation of the esophagus, stomach, and proximal duodenum paired with targeted mucosal pinch biopsies.

  • What It Looks For: Diagnoses structural, inflammatory, and immune-mediated enteropathies. Primary targets include duodenal villous blunting and intraepithelial lymphocytosis (celiac disease staged via Marsh-Oberhuber criteria), esophageal eosinophil density (at least 15 eosinophils per high-power field for eosinophilic esophagitis), Helicobacter pylori gastritis, gastric intestinal metaplasia or atrophy, peptic ulceration, and specialized intestinal metaplasia (Barrett esophagus).

Disaccharidase Enzyme Assay (Small Bowel Biopsy)

  • What It Is: A spectrophotometric biochemical analysis performed on snap-frozen endoscopic pinch biopsies from the second and third portions of the duodenum.

  • What It Looks For: Directly quantifies mucosal brush-border enzyme activity: lactase, sucrase, maltase, and palatinase (isomaltase). It identifies primary genetic disorders such as Congenital Sucrase-Isomaltase Deficiency (CSID) as well as acquired secondary deficiencies caused by mucosal injury, SIBO, celiac disease, or post-infectious enteritis.

Duodenal / Jejunal Aspirate for SIBO & SIFO (Bacterial & Fungal Cultures)

  • What It Is: Sterile intraluminal collection of proximal small bowel secretions through a dedicated endoscopic catheter trap.

  • What It Looks For: The quantitative culture standard for small bowel dysbiosis. Identifies Small Intestinal Bacterial Overgrowth (SIBO) based on bacterial colony counts of at least 1,000 CFU/mL (10^3 CFU/mL per ACG guidelines), and isolates Small Intestinal Fungal Overgrowth (SIFO, predominantly Candida albicans and Candida glabrata) via selective fungal smear and culture.

EndoFLIP (Endoluminal Functional Lumen Imaging Probe) – Esophageal & Pyloric

  • What It Is: High-resolution impedance planimetry utilizing a fluid-filled balloon catheter to quantify luminal geometry, cross-sectional area, and tissue compliance during sedated endoscopy.

  • What It Looks For: Measures the Distensibility Index (DI, reported in mm2/mmHg) and narrowest cross-sectional area (CSA). In the esophagus, it assesses lower esophageal sphincter (LES) compliance and secondary peristaltic contractility to identify achalasia subtypes, EGJ outflow obstruction, and non-obstructive dysphagia. At the gastric pylorus, it measures pyloric sphincter stiffness to detect pyloric dysfunction in gastroparesis.

Bravo 48- to 96-Hour Wireless Esophageal pH Monitoring

  • What It Is: An ambulatory radiotelemetry capsule deployed and clipped to the esophageal mucosa 6 cm proximal to the squamocolumnar junction (or 5 cm proximal to the manometrically localized LES).

  • What It Looks For: Quantifies esophageal acid exposure time (AET, the percentage of time luminal pH is less than 4.0) over multiple consecutive days. Evaluates total acid exposure, bolus clearing capacity, and symptom association indices (Symptom Index [SI] and Symptom Association Probability [SAP]) under Lyon Consensus 2.0 to confirm or refute pathological gastroesophageal reflux disease.

Endoscopic Botulinum Toxin Injection (Botox) – Pylorus & Lower Esophageal Sphincter

  • What It Is: Targeted chemical denervation via endoscopic injection needle into the muscularis propria of tonic sphincters.

  • What It Looks For / Indication: Cleaves SNAP-25 to block presynaptic acetylcholine release at the neuromuscular junction. At the LES, it lowers resting basal tone to relieve outflow resistance in nonsurgical achalasia or severe hypercontractile esophagus. At the gastric pylorus, circumferential injections reduce pylorospasm to decrease resistance to gastric emptying in refractory gastroparesis.

Colonoscopy with Terminal Ileum & Colonic Mucosal Biopsies

  • What It Is: Complete retrograde optical evaluation of the large intestine and terminal ileum with structural and random mapping biopsies.

  • What It Looks For: Visualizes mucosal ulceration, polyps, vascular patterns, and strictures. Biopsies distinguish Crohn disease from ulcerative colitis, diagnose microscopic colitis (lymphocytic colitis with at least 20 intraepithelial lymphocytes per 100 enterocytes; collagenous colitis with a subepithelial collagen band of at least 10 micrometers), and evaluate for infectious or ischemic colitis.

VASCULAR & ABDOMINAL RADIOLOGY

Mesenteric Duplex Ultrasound with Respiratory Maneuvers (MALS Screen)

  • What It Is: Dynamic transabdominal Doppler ultrasound assessing mesenteric arterial flow velocities during resting breathing, deep inspiration, and end-expiration.

  • What It Looks For: Screens for Median Arcuate Ligament Syndrome (MALS) by measuring peak systolic velocity (PSV) and deflection angles of the celiac artery. Identifies dynamic crural compression marked by elevated expiratory velocities (PSV exceeding 200 to 350 cm/s with post-stenotic turbulence) that normalize or significantly improve during deep inspiration.

CT Angiography (CTA) / MR Angiography (MRA) Abdomen (MALS & SMA Protocol)

  • What It Is: Contrast-enhanced cross-sectional 3D vascular imaging obtained during coordinated inspiratory and expiratory breath-holds.

  • What It Looks For: Visualizes focal hook-shaped celiac artery indentation and post-stenotic dilation in MALS. Concurrently measures the aortomesenteric angle (abnormal if less than 22 degrees) and aortomesenteric distance (abnormal if less than 8 mm) to diagnose duodenal compression in Superior Mesenteric Artery (SMA) syndrome.

Abdominal Radiograph (KUB / Flat Plate)

  • What It Is: A single-view plain projectional radiograph of the abdomen and pelvis.

  • What It Looks For: Evaluates gross colonic stool burden and segmental fecal distribution (using validated tools such as Leech or Starreveld scores), detects megacolon or mechanical obstruction patterns (air-fluid levels, dilated loops), and identifies occult fecal impaction presenting with paradoxical bypass diarrhea.

Transient Elastography (FibroScan)

  • What It Is: A non-invasive point-of-care ultrasound device measuring shear wave velocity through hepatic parenchyma.

  • What It Looks For: Generates a Liver Stiffness Measurement (LSM, reported in kilopascals [kPa]) to stage fibrosis (F0 to F4 / cirrhosis), combined with the Controlled Attenuation Parameter (CAP, reported in dB/m) to quantify hepatic steatosis in metabolic dysfunction-associated steatotic liver disease (MASLD/MASH) or drug toxicity.

MRI Liver with Magnetic Resonance Cholangiopancreatography (MRCP)

  • What It Is: Multiplanar contrast-enhanced hepatic MRI paired with heavily T2-weighted non-contrast biliary sequence reconstructions.

  • What It Looks For: Detailed anatomical evaluation of the gallbladder, intrahepatic/extrahepatic biliary tree, and pancreatic duct. Identifies choledocholithiasis, biliary strictures, ductal dilatations, sclerosing cholangitis changes, chronic pancreatitis, cystic neoplasms (IPMNs), and hepatic lesions.

ESOPHAGEAL & LOWER MOTILITY PHYSIOLOGY LABS

High-Resolution Esophageal Manometry (HRM)

  • What It Is: Transnasal solid-state multi-channel catheter profiling spatial and temporal pressure topographies across the upper sphincter, esophageal body, and LES during standardized swallows.

  • What It Looks For: Classifies esophageal motor function under Chicago Classification v4.0. Diagnoses disorders of EGJ outflow (Achalasia Types I, II, and III; EGJ Outflow Obstruction via elevated median Integrated Relaxation Pressure [IRP]) and peristaltic disorders (Hypercontractile/Jackhammer esophagus with Distal Contractile Integral [DCI] greater than 8,000 mmHg-s-cm; Distal Esophageal Spasm with Distal Latency under 4.5 seconds; Absent Contractility).

Ambulatory 24-Hour Catheter-Based pH-Impedance Monitoring

  • What It Is: Transnasal catheter monitoring pairing impedance rings with antimony pH sensors to evaluate intraluminal bolus movement and acidity for 24 hours.

  • What It Looks For: Detects acidic (pH less than 4.0), weakly acidic (pH 4.0 to 7.0), and non-acid reflux. Measures total Acid Exposure Time (AET), Mean Nocturnal Baseline Impedance (MNBI, assessing mucosal integrity), Post-Reflux Swallow-Induced Peristaltic Wave (PSPW) index (assessing chemical clearance), and symptom-reflux correlations.

4-Hour Solid-Phase Gastric Emptying Scintigraphy (GES)

  • What It Is: Quantitative radionuclide clearance imaging of a standardized radiolabeled solid meal (Technetium-99m egg whites) over 4 hours.

  • What It Looks For: Physiological rate of solid gastric transit. Confirms gastroparesis based on abnormal retention (greater than 10% retention at 4 hours or greater than 60% at 2 hours); identifies rapid gastric emptying/dumping syndrome if retention is less than 30% at 1 hour.

High-Resolution Anorectal Manometry (HRAM) & Balloon Expulsion Test (BET)

  • What It Is: Multi-sensor pressure recording of the rectal ampulla and anal canal paired with timed transanal expulsion of a water-filled balloon.

  • What It Looks For: Evaluates pelvic floor and anorectal neuromuscular coordination under the London Classification: basal resting pressure (internal sphincter), squeeze pressure and endurance (external sphincter and puborectalis), rectoanal inhibitory reflex (RAIR, absent in Hirschsprung disease), rectal sensory thresholds, pelvic floor dyssynergia (Types I through IV), and functional outlet obstruction (balloon expulsion taking longer than 60 seconds).

Dynamic Pelvic Defecography (MR or Fluoroscopic)

  • What It Is: Real-time dynamic imaging of pelvic organ support and evacuation during active straining and defecation.

  • What It Looks For: Diagnoses structural and functional pelvic floor evacuation disorders, including internal intussusception, high-grade rectocele, enterocele, cystocele, rectal prolapse, and paradoxical puborectalis non-relaxation.

Anorectal & Pelvic Floor Biofeedback Re-Education Sessions

  • What It Is: Instrumented neuromuscular operant conditioning utilizing pressure or EMG biofeedback.

  • What It Looks For / Retrains: Re-educates dyssynergic defecation by training patients to coordinate diaphragmatic push effort while relaxing the puborectalis muscle and external anal sphincter; restores sensory threshold awareness in visceral hyposensitivity.

INFLAMMATORY & BIOMARKER PANELS

Fecal Calprotectin & Fecal Lactoferrin

  • What It Is: Quantitative stool immunoassays measuring stable neutrophil cytosolic proteins shed into the gut lumen during active mucosal breakdown.

  • What It Looks For: Differentiates active organic bowel inflammation (Crohn disease, ulcerative colitis, infectious colitis) from non-inflammatory disorders of gut-brain interaction (IBS); monitors mucosal healing and screens for pouchitis.

Authoritative References

  1. Pimentel, M., Saad, R. J., Long, M. D., & Rao, S. S. C. (2020). ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. The American Journal of Gastroenterology, 115(2), 165–178.

  2. Yadlapati, R., Kahrilas, P. J., Fox, M. R., et al. (2021). Esophageal Motility Disorders on High-Resolution Manometry: Chicago Classification version 4.0. Neurogastroenterology & Motility, 33(1), e14058.

  3. Gyawali, C. P., Yadlapati, R., Fass, R., et al. (2024). Modern Diagnosis of GERD: The Lyon Consensus 2.0. Gut, 73(1), 153–171.

  4. Camilleri, M., Kuo, B., Nguyen, L., et al. (2022). ACG Clinical Guideline: Gastroparesis. The American Journal of Gastroenterology, 117(8), 1197–1220.

  5. Carrington, E. V., Heinrich, H., Knowles, C. H., et al. (2020). The International Anorectal Physiology Working Group Recommendations: Standardized Testing Protocol and London Classification for Disorders of Anorectal Function. Neurogastroenterology & Motility, 32(1), e13679.

Gutbraineducation.com
X